R-Biopharm   Report issue

For profit Phase 1 Phase 3
Founded: Darmstadt Germany (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2009
NCT01274975
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

R-Bio